Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Some psychiatric sits at the center of this dementia and brain health question.
Yes, psychiatric side effects from medications—particularly those used to treat neurological conditions like dementia—are frequently dismissed or minimized by healthcare providers, often without adequate investigation into their true impact on a patient’s quality of life. When an older adult on a new antipsychotic or antidepressant begins experiencing emotional blunting, increased anxiety, or behavioral changes, these symptoms are sometimes attributed to disease progression rather than medication effects, causing patients to suffer unnecessarily and potentially leading to cascading health problems. For example, a 72-year-old woman started on an antipsychotic for behavioral symptoms related to frontotemporal dementia developed severe apathy and stopped eating—symptoms her family initially worried meant her condition was worsening, only to discover months later that the medication itself had suppressed her appetite and motivation.
The problem runs deeper than simple oversight. Psychiatric side effects are inherently subjective, difficult to measure objectively, and can develop gradually over weeks or months, making them easy to overlook in rushed clinical visits. Moreover, there is often an implicit assumption in geriatric care that some degree of emotional dampening or personality change is an acceptable trade-off when managing behavioral problems in dementia—an assumption that prioritizes control over quality of life.
Table of Contents
- Why Are Psychiatric Medication Side Effects Overlooked in Dementia Care?
- The Clinical Dilemma—Balancing Behavioral Control Against Psychiatric Harm
- Real-World Examples of Dismissed Psychiatric Side Effects
- What Caregivers and Patients Can Do to Advocate for Proper Evaluation
- The Problem of Polypharmacy and Compounding Psychiatric Effects
- How to Distinguish Between Disease Progression and Medication Side Effects
- The Future of Psychiatric Side Effect Recognition in Dementia Care
- Conclusion
- Frequently Asked Questions
Why Are Psychiatric Medication Side Effects Overlooked in Dementia Care?
Healthcare providers face genuine challenges when evaluating psychiatric side effects in dementia patients, primarily because these individuals cannot always clearly articulate their internal emotional states. A person with moderate Alzheimer’s disease may not be able to describe feeling emotionally numb or anxious in a way that gets properly documented or weighted against the medication’s intended benefits. This communication barrier creates a blindspot: clinicians often rely on behavioral observations rather than the patient’s subjective experience, which means side effects that don’t manifest as obvious behavioral changes can slip through unnoticed.
The time constraints of modern healthcare also play a role. Many primary care physicians and neurologists see patients for 15-20 minutes, which is often insufficient time to distinguish between medication side effects and disease symptoms, especially when both can present similarly. Apathy and social withdrawal, for instance, occur naturally in dementia progression but are also common side effects of antipsychotics and selective serotonin reuptake inhibitors (SSRIs). Without dedicated time to explore the timeline and compare the patient’s baseline functioning before medication changes, clinicians may chalk everything up to disease progression and continue or increase the offending medication.
The Clinical Dilemma—Balancing Behavioral Control Against Psychiatric Harm
When a dementia patient becomes aggressive, agitated, or exhibits disturbing behaviors, there is genuine clinical pressure to treat these symptoms quickly and effectively. psychiatric medications, particularly antipsychotics, do suppress agitation—but they do so partly through emotional blunting and psychomotor slowing, which many consider acceptable side effects given the alternatives (behavioral crisis, safety risks, caregiver burnout). However, this calculus often lacks transparency; patients and families are rarely told that the goal of medication is partly achieved by dampening the person’s emotional life and cognitive responsiveness.
A crucial limitation of this approach is that it assumes behavioral control is the primary outcome that matters. But quality of life—the ability to feel engaged with loved ones, to enjoy activities, to retain personality—matters deeply to people living with dementia and their families. When psychiatric medications remove agitation at the cost of rendering someone emotionally flat or indifferent, the “solution” may create a different problem. Additionally, some psychiatric side effects can be paradoxical or delayed; a patient may experience increased anxiety or depression weeks after starting a medication that was meant to treat those very symptoms, a phenomenon that can be misinterpreted as worsening psychiatric illness rather than a medication effect.
Real-World Examples of Dismissed Psychiatric Side Effects
Consider the case of an 68-year-old man with mild cognitive impairment who was prescribed an SSRI for anxiety symptoms. Within three weeks, he became emotionally distant from his wife and stopped engaging in hobbies he had previously enjoyed. His neurologist attributed this change to disease progression and recommended adding an antipsychotic. It was only when his wife, frustrated and concerned, brought him to a psychiatrist for a second opinion that the sequence of events was properly reviewed—and both medications were slowly tapered. His personality and engagement returned within weeks.
This case illustrates how easily psychiatric side effects can be misdiagnosed as worsening disease, leading to further medication escalation rather than adjustment. Another example involves an 81-year-old woman with vascular dementia who experienced vivid nightmares and increased irritability after starting an anticholinergic medication for urinary symptoms (a common problem in older adults). Her family noticed she seemed “angrier” and less patient with her grandchildren. Rather than connecting this to the medication, her primary care doctor noted her behavioral changes and discussed starting a mood stabilizer. Fortunately, a geriatric pharmacist caught the issue and recommended switching to a different medication class. The nightmares and irritability resolved, avoiding unnecessary psychiatric polypharmacy.
What Caregivers and Patients Can Do to Advocate for Proper Evaluation
Documenting changes carefully is one of the most powerful tools available to patients and families. Keep a simple timeline: note what medications were started or changed, and when behavioral or emotional symptoms began. A written record showing that apathy started exactly one week after beginning a new antidepressant carries more weight in a clinical conversation than a vague report that “something seems off.” Bring this documentation to appointments and explicitly ask your doctor whether observed changes could be medication-related. Asking direct questions during appointments—”Could this side effect be coming from the medication rather than the disease?” or “How will we know if this medication is causing more harm than benefit?”—shifts the burden of proof.
Many clinicians will default to continuing a medication unless actively prompted to consider alternatives. Another strategy is to request a trial period where the medication is reduced or paused (if medically safe to do so) to see whether psychiatric symptoms improve. This can be clarifying in ways that clinical observation alone cannot. Finally, involving a geriatric psychiatrist or pharmacist in medication reviews, particularly if a patient is on multiple psychiatric drugs, can catch interactions and side effects that primary care doctors may miss due to time constraints or limited specialized knowledge.
The Problem of Polypharmacy and Compounding Psychiatric Effects
Many older adults with dementia are on multiple medications simultaneously, and psychiatric side effects become far more complex in this context. An SSRI might cause emotional blunting, an antipsychotic might add apathy, and an anticholinergic medication for another condition might impair cognition further—and together, these create a state that looks like advanced dementia but is actually largely iatrogenic (caused by treatment). The risk is that clinicians, seeing profound functional decline, may increase doses or add yet another medication, creating a downward spiral.
A major limitation of polypharmacy management is that it often goes unmonitored systematically. Medications accumulate over time as different specialists add drugs for different problems, but there may be no single clinician responsible for stepping back and asking whether the total medication burden is still appropriate. This is especially true in dementia care, where the patient cannot voice concerns about side effects and the focus often remains on treating each symptom in isolation. Additionally, older adults metabolize medications differently than younger adults, and dementia can further affect drug clearance, meaning that standard doses can accumulate to toxic levels—worsening psychiatric symptoms in the process.
How to Distinguish Between Disease Progression and Medication Side Effects
One practical approach is to consider timing and trajectory. Psychiatric symptoms that develop shortly after a medication change are more likely to be medication-related, while gradual changes over months or years are more consistent with disease progression. Dementia typically evolves slowly and somewhat predictably; sudden mood shifts, personality changes, or new anxiety are more often triggered by acute factors, including medications.
Additionally, certain patterns suggest side effects: if emotional blunting coincides with introduction of an antipsychotic, or anxiety spikes after starting an SSRI, these temporal relationships are clinically meaningful. Families can also rely on insight from people who knew the patient well before cognitive decline. A spouse or adult child can often distinguish between the “slow fade” of advancing dementia and the “sudden shift” that accompanies a medication effect. This lived knowledge, while anecdotal, is valuable and should be taken seriously in clinical discussions.
The Future of Psychiatric Side Effect Recognition in Dementia Care
There is growing recognition within geriatric medicine that psychiatric side effects are underdetected and undervalued in dementia populations. More training programs are emphasizing the subjective experience of dementia patients and the importance of quality-of-life measures alongside behavioral control.
Additionally, standardized screening tools for psychiatric side effects—similar to those used for physical medication toxicity—are being developed and integrated into clinical practice. The goal is to shift the paradigm from “behavioral management at any cost” to “finding the balance between symptom control and preserving the person.” The hope is that future approaches to dementia care will involve systematic medication reviews, explicit conversations about trade-offs between behavioral control and emotional engagement, and greater humility about attributing all changes to disease progression. When families and patients are educated about the possibility of psychiatric side effects and encouraged to report them without judgment, detection rates improve, and unnecessary medication escalation can be avoided.
Conclusion
Psychiatric side effects from medications used in dementia care are indeed dismissed too quickly, often due to communication barriers, time constraints in clinical practice, and implicit assumptions that emotional blunting is an acceptable trade-off for behavioral control. The consequences can be profound: patients may lose engagement with their lives and loved ones, become unnecessarily disabled, or receive additional medications to treat side effects from previous medications. Caregivers and patients have significant power in this situation through careful documentation, direct questioning, and involvement of specialists in medication review.
By treating psychiatric side effects with the same seriousness as physical side effects, and by regularly asking whether observed changes represent disease progression or medication toxicity, we can ensure that dementia treatment enhances rather than diminishes quality of life. If you or a family member are managing dementia and notice psychiatric changes after a medication adjustment, request a medication review with your doctor, bring written documentation of symptom timelines, and consider asking for a second opinion from a geriatric psychiatrist or pharmacist. These steps take time and persistence, but they can mean the difference between a life lived with emotional engagement and one lived in pharmaceutical haze.
Frequently Asked Questions
How long after starting a medication should I worry that psychiatric changes are side effects?
Most medication side effects appear within days to weeks, though some take several weeks to develop. If psychiatric symptoms start within a few weeks of a medication change, it’s worth discussing with your doctor. Conversely, gradual changes over months may reflect disease progression, but this should still be evaluated.
Can psychiatric side effects go away on their own if I wait longer?
Some side effects do resolve with time as the body adjusts (a process that may take several weeks), but others persist or worsen. Rather than waiting passively, discuss with your doctor whether a dose adjustment, time frame for tolerance, or switch to an alternative medication makes sense. Waiting too long risks the patient experiencing unnecessary suffering.
If my family member improves when we reduce a psychiatric medication, does that prove it was causing side effects?
Improvement after dose reduction or discontinuation is strong evidence that the medication was contributing to psychiatric symptoms. This kind of real-world trial can be more informative than clinical observation alone. However, always work with your doctor when adjusting medications, as some need to be tapered slowly.
Are certain psychiatric medications more likely to cause side effects in dementia patients?
Antipsychotics, anticholinergics, and some antidepressants carry higher risks of psychiatric side effects in older adults and those with dementia. Newer antipsychotics tend to have lower rates of emotional blunting than older agents, but individual variation is significant. A geriatric psychiatrist can help identify lower-risk options tailored to your situation.
What should I do if my doctor dismisses my concerns about psychiatric side effects?
Request a second opinion, bring written documentation of symptom timing, and ask specific questions about whether the observed changes could be medication-related. If your concerns continue to be dismissed, consider consulting a geriatric psychiatrist or pharmacist who specializes in dementia care. Advocating persistently, while respectfully, is often necessary.
You Might Also Like
- Could Some Medication Side Effects Be Mistaken for New Mental Health Problems
- Why More Former Patients Are Speaking Out About Psych Med Withdrawal
- Can Psychiatric Medications Cause Lasting Harm Years Later
For more, see Alzheimer’s Association — caregiving.
